Drug news
FDA approves cobas CMV (cytomegalovirus) test- Roche
Roche announced that it has received FDA approval for the cobas CMV (cytomegalovirus) test for use on the fully automated cobas 6800 and cobas 8800 Systems. The test is standardized to the 1st WHO International Standard for improving harmonization in CMV testing results across hospital institutions.
The fully automated cobas CMV Test can be run simultaneously with HIV-1 or HCV assays on the cobas 6800/8800 Systems, streamlining workflow while increasing flexibility for patient sample management.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins